Adimab, Inc. Receives $6,000,000 Series A Round

  • Feed Type
  • Date
    7/20/2007
  • Company Name
    Adimab, Inc.
  • Mailing Address
    16 Cavendish Court Lebanon, NH 03766
  • Company Description
    Adimab–which stands for Antibody Discovery Maturation Biomanufacturing–is developing a platform that’s deliberately engineered to minimize and potentially eliminate third party royalties, offering a one-stop-service-shop to a select few Big Pharma partners.
  • Website
    http://www.adimab.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    Polaris Venture Partners

By posting a comment, you agree to our terms and conditions.